Cargando…
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data
Autores principales: | Song, Haiping, Arredondo Carrera, Hector Manuel, Sprules, Alexandria, Ji, Ying, Zhang, Tongsong, He, Jiepei, Lawrence, Eleanor, Gartland, Alison, Luo, Jian, Wang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009667/ https://www.ncbi.nlm.nih.gov/pubmed/36582013 http://dx.doi.org/10.1002/cac2.12391 |
Ejemplares similares
-
Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target
por: He, Jiepei, et al.
Publicado: (2020) -
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis()()
por: Gartland, Alison, et al.
Publicado: (2016) -
PTH(1–34) treatment and/or mechanical loading have different osteogenic effects on the trabecular and cortical bone in the ovariectomized C57BL/6 mouse
por: Roberts, Bryant C., et al.
Publicado: (2020) -
P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis
por: Wang, Ning, et al.
Publicado: (2018) -
Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
por: Lowes, Lori E., et al.
Publicado: (2016)